Journal

Move clinical AI procurement beyond badges by checking scope, usable evidence, change commitments, incident cooperation and practical exit arrangements.

Follow a fictional referral-drafting workflow from hazards and controls to verification requirements and a conditional clinical safety release decision.

Build a clinical AI evidence pack around claims, relevant evaluations, human factors, limitations and lifecycle responsibilities rather than a pile of certificates.

A clinical AI platform's certification claim must match the functions, intended purpose and configuration assessed, not simply its shared brand.

Clinical AI assessment bodies need competence and independence; venture-backed growth raises governance questions, not automatic evidence of compromised scrutiny.

Map the distinct roles of manufacturers, regulators, conformity assessors, clinical safety officers and NHS adopters before a clinical AI launch.

A third-party language model does not automatically prevent medical-device certification, but manufacturers must evaluate and control the finished clinical system.

Understand the difference between Scarlet's assessment schemes, medical-device conformity and the local evidence needed to use clinical AI responsibly.

How to assess whether healthcare AI uses proportionate resources, with task-level evidence rather than universal claims about energy per query.

How clinical AI activity data could become workplace monitoring, why usage does not prove competence, and what UK organisations should assess.

How clinical training can preserve reasoning, feedback and supervised practice when AI takes on routine work, without retaining needless administration.

What NHS teams should establish before expanding a clinical AI pilot, including outcomes, workload, equity, scope and conditions for stopping.